Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 352 entries
View as:

Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03401671 Org: User:
Start: 01/15/18 End: 05/30/18 Due: 05/30/19

Treatment Protocol of Replagal for Patients With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT01031173 Org: User:
Start: - End: - Due: -

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Phase: N/A Priority: Normal
NCT ID: NCT01147302 Org: User:
Start: 08/24/11 End: 06/28/13 Due: 06/28/14

Head to Head Study Against Sevelamer Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT00441545 Org: User:
Start: 01/05/07 End: 07/31/08 Due: 07/31/09

SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00985725 Org: User:
Start: 10/29/09 End: 04/18/11 Due: 04/18/12

An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access

Phase: N/A Priority: Normal
NCT ID: NCT01806545 Org: User:
Start: 03/26/13 End: 10/27/14 Due: 10/27/15

Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution

Phase: N/A Priority: Normal
NCT ID: NCT00776555 Org: User:
Start: 11/21/08 End: 03/31/09 Due: 03/31/10

Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)

Phase: N/A Priority: Normal
NCT ID: NCT00069641 Org: User:
Start: 09/18/03 End: 03/16/05 Due: 03/16/06

Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT00553631 Org: User:
Start: 01/29/08 End: 05/05/09 Due: 05/05/10

French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia

Phase: N/A Priority: Normal
NCT ID: NCT01192347 Org: User:
Start: 09/13/10 End: 12/21/12 Due: 12/21/13

Efficacy and Safety of SPD465 in Adults With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00150579 Org: User:
Start: 01/27/05 End: 06/14/05 Due: 06/14/06

Drug Use Study With Intuniv® in Australia

Phase: N/A Priority: Normal
NCT ID: NCT04866030 Org: User:
Start: 03/11/19 End: 08/27/21 Due: 08/27/22

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01276509 Org: User:
Start: 04/06/11 End: 10/09/15 Due: 10/09/16

A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

Phase: N/A Priority: Normal
NCT ID: NCT01297309 Org: User:
Start: 04/06/11 End: 06/08/18 Due: 06/08/19

Pediatric Disease Registry in Essential Thrombocythaemia (ET)

Phase: N/A Priority: Normal
NCT ID: NCT01198717 Org: User:
Start: 09/28/10 End: 03/01/16 Due: 03/01/17

Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

Phase: N/A Priority: Normal
NCT ID: NCT01467661 Org: User:
Start: 10/27/10 End: 05/01/15 Due: 05/01/16

An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)

Phase: N/A Priority: Normal
NCT ID: NCT01093105 Org: User:
Start: 04/01/10 End: 05/01/12 Due: 05/01/13

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Phase: N/A Priority: Normal
NCT ID: NCT01500694 Org: User:
Start: 03/20/12 End: 09/15/15 Due: 09/15/16

Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00399308 Org: User:
Start: 01/31/07 End: 04/30/08 Due: 04/30/09

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

Phase: N/A Priority: Normal
NCT ID: NCT01470469 Org: User:
Start: 01/04/12 End: 07/15/13 Due: 07/15/14

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00880750 Org: User:
Start: 01/28/09 End: 06/22/09 Due: 06/22/10

Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Phase: N/A Priority: Normal
NCT ID: NCT01299727 Org: User:
Start: 03/01/11 End: 04/12/19 Due: 04/12/20

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Phase: N/A Priority: Normal
NCT ID: NCT01147926 Org: User:
Start: 09/23/10 End: 10/25/13 Due: 10/25/14

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01552902 Org: User:
Start: 04/03/12 End: 05/22/14 Due: 05/22/15

Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT02865720 Org: User:
Start: 09/08/16 End: 06/23/17 Due: 06/23/18